Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Thank you for subscribing to CAS Insights™.
You can look forward to new opportunities on the topics that are driving scientific progress across the world.
Only CAS combines the birds-eye view of the world's science with deep expertise from hundreds of scientists to reveal the hidden potential ahead.
Latest from CAS Insights™
Biotechnology
Microelectronics frontiers: insights into emerging technologies
How can researchers identify emerging trends in a massive field like microelectronics? Our analysis reveals breakthroughs across materials, devices, applications, and fabrication methods.
Biotechnology
The future of epigenetics: Emerging technologies and clinical applications
Epigenetics is the study of changes in gene expression that don’t alter DNA sequences. Understanding these processes is driving more personalized medicine and innovative therapies.